Revvity climbs after forecasting upbeat 2026 profit on diagnostics strength

Revvity

02/02/2026 13:24

** Shares of medical equipment maker Revvity RVTY.N rise 2% to $111 premarket

** Co forecasts 2026 adjusted profit per share of $5.35 to $5.45 vs analysts' average estimate of $5.32 - LSEG data

** RVTY reports Q4 adj. profit of $1.70/shr vs estimates of $1.55/shr

** Co's quarterly revenue of $772.1 million beats analysts' expectation of $761.3 million

** Up to last close, stock down 14.3% in last 12 months

 (Reporting by Christy Santhosh)

 ((Christy.Santhosh@thomsonreuters.com))